GO | Name |
GO:0000785 | chromatin |
GO:0000976 | transcription cis-regulatory region binding |
GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO:0001656 | metanephros development |
GO:0001756 | somitogenesis |
GO:0001934 | positive regulation of protein phosphorylation |
GO:0003700 | DNA-binding transcription factor activity |
GO:0004879 | nuclear receptor activity |
GO:0005634 | nucleus |
GO:0005654 | nucleoplasm |
GO:0005829 | cytosol |
GO:0006355 | regulation of transcription, DNA-templated |
GO:0006357 | regulation of transcription by RNA polymerase II |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0007275 | multicellular organism development |
GO:0007431 | salivary gland development |
GO:0007507 | heart development |
GO:0008134 | transcription factor binding |
GO:0008284 | positive regulation of cell population proliferation |
GO:0008285 | negative regulation of cell population proliferation |
GO:0008584 | male gonad development |
GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process |
GO:0010628 | positive regulation of gene expression |
GO:0010629 | negative regulation of gene expression |
GO:0010942 | positive regulation of cell death |
GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0030154 | cell differentiation |
GO:0030284 | estrogen receptor activity |
GO:0030331 | estrogen receptor binding |
GO:0030521 | androgen receptor signaling pathway |
GO:0032880 | regulation of protein localization |
GO:0033574 | response to testosterone |
GO:0035690 | cellular response to drug |
GO:0035907 | dorsal aorta development |
GO:0042826 | histone deacetylase binding |
GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0043491 | protein kinase B signaling |
GO:0043565 | sequence-specific DNA binding |
GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway |
GO:0043621 | protein self-association |
GO:0045892 | negative regulation of transcription, DNA-templated |
GO:0045893 | positive regulation of transcription, DNA-templated |
GO:0045930 | negative regulation of mitotic cell cycle |
GO:0045931 | positive regulation of mitotic cell cycle |
GO:0045944 | positive regulation of transcription by RNA polymerase II |
GO:0048754 | branching morphogenesis of an epithelial tube |
GO:0050680 | negative regulation of epithelial cell proliferation |
GO:0051091 | positive regulation of DNA-binding transcription factor activity |
GO:0051781 | positive regulation of cell division |
GO:0060037 | pharyngeal system development |
GO:0060442 | branching involved in prostate gland morphogenesis |
GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development |
GO:0071347 | cellular response to interleukin-1 |
GO:0071356 | cellular response to tumor necrosis factor |
GO:0071383 | cellular response to steroid hormone stimulus |
GO:0071456 | cellular response to hypoxia |
GO:0071899 | obsolete negative regulation of estrogen receptor binding |
GO:0090734 | site of DNA damage |
GO:0097162 | MADS box domain binding |
GO:1990837 | sequence-specific double-stranded DNA binding |
GO:2000836 | positive regulation of androgen secretion |
GO:2001022 | positive regulation of response to DNA damage stimulus |
GO:2001235 | positive regulation of apoptotic signaling pathway |
GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway |